FDA slow to encourage lupus drugs.
Webber
D
D
D002986:Clinical Trials as Topic / Q000592:standards*; D017277:Drug Approval; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration